PRTN3 and rheumatoid arthritis: •Serum anti-MAA (IgG) Ab increased in RA vs. control; not RA-specific•Low correlation with other AMPAs but unique positive correlations with RA disease activity•Not increased in at risk RA•No cross reactivity with ACPA or other RA-autoAb